item management s discussion and analysis of financial condition and results of operations 
overview hcia inc hcia or the company is a health care information content company that develops and markets integrated clinical information systems and products 
the company s systems and products range from standardized databases to highly focused decision support systems that assist its customers in evaluating the efficacy and economics of health care delivery 
the company s customers include hospitals  integrated delivery systems  self insured employers  pharmaceutical companies and managed care organizations 
the company has made a substantial investment in the acquisition and development of its core collection of methodologies  clinical measurement tools and technical resources 
in addition to internal development efforts  the company has made a series of acquisitions of other health care information companies  product lines and data resources 
the company s strategy is to integrate and leverage these developed and acquired resources across substantially all of its systems and products  thereby giving it the ability to increase revenue generated from these resources without a commensurate increase in expenses 
the company does not track profitability by product line since many of the company s resources are utilized throughout its systems and products 
in connection with certain acquisitions  the company has recorded one time charges related to acquired in process research and development costs 
such charges totaled approximately million and million during and  respectively 
during  the company recorded a charge totaling million related to an impairment loss on intangible assets and a restructuring charge related primarily to the company s acquisition of lba health care management  inc lba 
the company has accounted for all of its acquisitions using the purchase method of accounting and  accordingly  has included the results of the acquired entities since the dates of acquisition 
see note of the notes to consolidated financial statements 
the company s internal product development efforts are generally in connection with customer contracts  and the related costs are included as a component of operating expenses in the year incurred 
the company capitalizes costs related to internal product development which is not in connection with a specific customer contract from the point of technological feasibility to the point of general availability 
as a result of its acquisitions of health care information companies  product lines and data resources  the company has acquired intangible assets  the cost of which it amortizes over various useful lives 
in addition  the company has capitalized internal development costs and acquired assets relating to the development of methodologies  clinical measurement tools and technical resources  including its database  of million  million and million during  and  respectively 
consequently  the company has recorded amortization expense of million  million and million during  and  respectively 
see notes   and of the notes to consolidated financial statements 
as a result of its unique ability to integrate health care data collected from numerous sources and across varied treatment settings  the company believes that it is well positioned to offer the information systems and products necessary to continue to increase average revenue per customer through the sale of more sophisticated and comprehensive systems and products 
with respect to entry level systems and products  pricing is relatively fixed and is influenced by competitive systems and products 
with respect to high end systems and products  pricing is often negotiated with the customer and is based on a number of factors  including the value attributed by the customer to the system 
during  the company reorganized its internal sales and marketing structure into four business units content  which focuses on distributing standard data content products  integrated solutions  which aligns multiple hcia competencies to create an integrated solution for a client  implementation  which provides data focused implementation services to providers  and hcia europe 
effective in  the company began tracking its revenue through the four units  in lieu of its historical tracking of revenue by sales of decision support systems and syndicated products 
results of operations the following table sets forth  for the fiscal periods indicated  certain items from the consolidated statements of operations of the company expressed as a percentage of revenue year ended december  revenue salaries  wages and benefits other operating expenses depreciation and amortization write off of acquired in process research and development costs impairment loss on intangible assets and restructuring charges operating loss interest income  net loss before income taxes provision benefit for income taxes net loss compared to revenue revenue for was million  an increase of million or over the increase was primarily the result of increased sales in by the company s integrated solutions and implementation units 
the increase in integrated solutions sales was the result of the inclusion of a full year s revenue from healthchex  inc healthchex and response healthcare information management  inc response  both of which were acquired in  and increased penetration of the pharmaceutical market 
sales by the implementation unit increased as a result of the inclusion of a full year s revenue of lba  which was acquired in during  revenue historically classified as from sales of decision support systems represented approximately of revenue and syndicated products represented the remaining of revenue 
all of the company s revenue growth in was the result of increased sales of decision support systems 
salaries  wages and benefits salaries  wages and benefits increased to of revenue for from for the increase was primarily the result of the company establishing staffing levels in anticipation of a higher revenue level than actually achieved during the second and third quarters of and the company s decision to maintain staffing levels in the fourth quarter of at a level which would be necessary to support higher levels of revenue for other operating expenses other operating expenses  which include occupancy  travel and consulting expenses  increased to of revenue for from for this increase was a result of the company establishing levels for certain of these expenses  primarily consulting and occupancy  in anticipation of a higher revenue level than actually achieved in depreciation and amortization depreciation and amortization increased to of revenue for from for this increase was primarily a result of the additional amortization and depreciation associated with the acquisitions of healthchex  response and lba 
write off of acquired in process research and development costs in connection with the acquisitions of response  healthchex and lba during  the company acquired ongoing research and development activities 
the company recorded one time charges totaling million during  resulting from the write off of the acquired in process research and development costs 
the amount of the one time charges was equal to the estimated current fair value  based on the discounted risk adjusted cash flows  of specifically identified technologies for which technological feasibility had not yet been established pursuant to statement of financial accounting standards no 
 accounting for the costs of computer software to be sold  leased or otherwise marketed  and for which future alternative uses did not exist 
impairment loss on intangible assets and restructuring charges during  the company recorded an impairment loss on intangible assets and restructuring charges of approximately million 
approximately million of the charges represented the write down of certain intangibles  which arose from the company s acquisition of lba  to their estimated realizable value 
the charge resulted from the assessment that the company s implementation unit  formed upon the acquisition of lba  would not generate the cash flows anticipated at the time of the lba acquisition 
the remainder of the charges  totaling million  represented reserves for the cost of employee severance  facilities reduction  and customer allowances related to product discontinuances  which were incurred primarily in connection with restructuring the ongoing operations of the implementation unit 
interest income and expense net interest income was  for compared with  for this change was the result of a lower invested balance in due to the use of cash for acquisitions and to fund internal development costs and equipment acquisitions 
income taxes the company s effective income tax rate was for compared with for the change in the rate results from the effect of the non deductible write off of the in process research and development costs resulting from certain acquisitions during  which was partially offset by the increased amortization of non deductible goodwill during see note of the notes to consolidated financial statements 
compared to revenue revenue for was million  an increase of million or over the increase was the result of increased sales of the company s decision support systems 
revenue from the sales of decision support systems represented of revenue for and syndicated products represented the remaining of revenue 
the decision support systems revenue increase was primarily the result of increased sales to providers and managed care customers  particularly as a result of acquisitions  as well as increased penetration of the supplier market 
salaries  wages and benefits salaries  wages and benefits decreased to of revenue for from for this decrease was a result of the continued leveraging of the company s historical investments in technology and basic infrastructure as revenue increased 
other operating expenses other operating expenses  which include occupancy  travel and marketing expenses  decreased to of revenue for from for this decrease was a result of certain of these expenses growing at a slower rate than revenue 
depreciation and amortization depreciation and amortization increased to of revenue for from for this increase was a result of the additional amortization associated with certain acquisitions and capitalized internal development costs as well as depreciation of other acquired assets 
write off of acquired in process research and development costs in connection with four acquisitions completed during and  the company acquired ongoing research and development activities 
the company recorded one time charges totaling million and million during and  respectively  resulting from the write off of the acquired in process research and development costs 
the amount of the one time charges was equal to the estimated current fair value  based on the discounted risk adjusted cash flows  of specifically identified technologies for which technological feasibility had not yet been established pursuant to statement of financial accounting standards no 
 accounting for the costs of computer software to be sold  leased or otherwise marketed  and for which future alternative uses did not exist 
interest income and expense net interest income was  for compared with million for the decrease was the result of higher interest expense in related to debt incurred in connection with certain acquisitions 
income taxes the company s effective income tax rate was for compared with for the change was primarily the result of non deductible goodwill and the non deductible write off of the in process research and development costs resulting from certain acquisitions during liquidity and capital resources during and  the company completed several public offerings of its common stock 
the net proceeds to the company from the offerings were approximately million 
in august  the company obtained from first union national bank of north carolina first union a credit facility totaling million  consisting of a million term loan and a million revolving line of credit 
the company incurred a one time facility fee of  the company borrowed the entire million term loan and approximately million of the revolving line of credit in connection with the acquisition of lba and repaid such borrowings with a portion of the net proceeds to the company from a public offering of the company s common stock 
during  the company reduced the amount available under the revolving line of credit and currently maintains a million subject to certain borrowing limitations revolving line of credit for general corporate purposes  including future acquisitions and working capital requirements 
borrowings are collateralized by substantially all of the company s assets 
the company is required to pay a commitment fee on the average daily unused portion of the facility at a rate ranging from to per annum  depending on the company s debt cash flow ratio 
borrowings bear interest at varying rates based on an index tied to first union s prime rate or libor 
the credit facility also contains financial covenants applicable to hcia  including a debt cash flow ratio and ratios of debt to capital 
as of december   the company was in compliance with all such financial covenants and had a maximum borrowing capacity of million  and there were no borrowings outstanding under the facility 
the credit facility reduces to million in july  million in july and expires on july  during  and  the company generated net cash from operations of approximately million  million and million  respectively 
during and  approximately million and million of cash generated from operations was used to fund the increase in accounts receivable 
the increases in accounts receivable were primarily the result of revenue growth  as well as the timing of receipt of payments from certain major customers 
net cash provided used by financing activities during  and was approximately million  million and 
million  respectively 
the cash generated by financing activities in and was primarily a result of the company s public offerings of its common stock 
the net cash provided by operations and financing activities has been utilized primarily for acquisitions  software development costs and capital expenditures 
the company made capital expenditures including capitalized leases totaling million  million and million during  and  respectively 
as of december   the company had net working capital of million  including cash and cash equivalents in the amount of million  and did not have any material commitments for capital expenditures 
in april  the company completed the acquisition of all of the outstanding capital stock of datis corporation datis for million in cash  which included approximately million funded by the company and  funded with the proceeds received from the exercise of certain options to purchase datis stock and repaid approximately  of outstanding debt of datis 
in december  the company acquired the champ unit of william m 
mercer  incorporated champ for million in cash and  in may  the company completed the acquisition of response for approximately million in cash 
in august  the company acquired lba for a total purchase price of approximately million  million of which was paid in cash and million of which was paid by the delivery of hcia common stock 
the company utilized million in borrowings under the first union credit facility discussed above to fund the cash portion of the purchase price  which was subsequently repaid from the proceeds of a public offering of common stock 
in december  the company acquired healthchex from equifax inc for million in cash 
each of these acquisitions has been accounted for using the purchase method of accounting and  accordingly  the assets have been valued at their estimated fair market value 
year computer software the company has performed a review of its computer systems and software and has begun to implement the required revisions in anticipation of the year the company believes that its primary exposure to the issue is in the ability of its systems to recognize four digit references versus two digit references ie  versus and to accept such information from its customers in the process of building its databases 
at this time  the company has completed the required revisions to certain of its main processing systems to make them year compliant and has scheduled the remainder of its efforts such that they should be completed by june the company believes that to a significant extent  the necessary revisions to its systems and products will be made during the planned updates and edits to its product offerings 
as a result  the cost of the efforts performed to date and the incremental future costs the company expects to incur to make all of its systems and processes year compliant are not anticipated to be material to the company s results of operations  liquidity or capital resources 
while the company  in the process of making its systems year compliant  intends to design algorithms to test data received from its customers and convert it to a usable format  there can be no assurances that the company will not experience difficulties in utilizing data provided by its customers who have not taken the necessary steps to make their internal systems year compliant 
it is not currently possible to estimate the effect on the company s results of operations from any such difficulties 
new accounting pronouncements in  the financial accounting standards board issued statements of financial accounting standards no 
 reporting comprehensive income and no 
 disclosures about segments of an enterprise and related information 
in addition  the american institute of certified public accountants issued statement of position no 
 software revenue recognition during the company will adopt the provisions of these pronouncements in and has determined that they will not have a material effect on its financial position or results of operation and is assessing their effect on its financial statement presentation and disclosure 
forward looking statements this management s discussion and analysis of financial condition and results of operations and other sections of this form k contain forward looking statements  including statements regarding the intent  belief or current expectations of the company and its management 
these statements are not guarantees of future performance and involve a number of risks and uncertainties which are difficult to predict 
therefore  actual outcomes and results could differ materially from those indicated by such forward looking statements 
hcia undertakes no obligation to publicly update any forward looking statements  whether as a result of new information  future events or otherwise 
among the important factors that could cause actual results to differ materially from those indicated by such forward looking statements are i variations in quarterly results  ii the assimilation of acquisitions  iii the management of the company s growth and expansion  iv dependence on key personnel  v development by competitors of new or superior products or entry into the market of new competitors  vi dependence on major customers  vii dependence on intellectual property rights  viii integrity  availability and reliability of the company s data  ix volatility of the company s stock price  x changes in the health care industry from both a regulatory and financial perspective  xi implementation of required changes to computer systems and software for the year  and xii other risks identified from time to time in the company s reports and registration statements filed with the securities and exchange commission 

